Showing results (71-80 of 158) with videos related to
Sort By:
Pageof 16
Plos One|July 13, 2023
Comparison of visual performance between bifocal and extended-depth-of-focus intraocular lensesHitoshi Tabuchi, Hirotaka Tanabe, Tomoki Shirakami, et al.The Journal of Gene Medicine|November 22, 2022
Evaluation of CRISPR/Cas9 exon-skipping vector for choroideremia using human induced pluripotent stem cell-derived RPEToshiro Iwagawa, Hiroki Masumoto, Hitoshi Tabuchi, et al.Journal of Glaucoma|June 9, 2016
A Pilot Evaluation Assessing the Ease of Use and Accuracy of the New Self/Home-Tonometer IcareHOME in Healthy Young SubjectsAsuka Noguchi, Shunsuke Nakakura, Yuki Fujio, et al.Case Reports in Ophthalmology|February 4, 2020
CHARGE Syndrome Associated with Angle Closure despite High Myopia: A Case Report with Structural SuggestionSaki Dote, Shunsuke Nakakura, Hirotaka Tanabe, et al.Scientific Reports|March 30, 2020
Choroidal thickness estimation from colour fundus photographs by adaptive binarisation and deep learning, according to central serous chorioretinopathy statusYuki Komuku, Atsuya Ide, Hisashi Fukuyama, et al.Journal of Cataract and Refractive Surgery|August 20, 2021
Examination of the safety and effectiveness of low-concentration nitrous oxide anesthesia in cataract surgerySantaro Noguchi, Shunsuke Nakakura, Asuka Noguchi, et al.Plos One|May 1, 2014
Cross-sectional study of the association between a deepening of the upper eyelid sulcus-like appearance and wide-open eyesShunsuke Nakakura, Etsuko Terao, Nozomi Nagatomi, et al.Turkish Journal of Ophthalmology|February 26, 2021
A Case of Paracentral Corneal Perforation Treated with One-Bite Mini-KeratoplastyYoshitake Kato, Daisuke Nagasato, Shunsuke Nakakura, et al.Retina (Philadelphia, Pa.)|March 20, 2018
MORPHOLOGIC CHARACTERISTICS OF MACULAR HOLE AND MACULAR HOLE RETINAL DETACHMENT ASSOCIATED WITH EXTREME MYOPIAHideharu Ohsugi, Yasushi Ikuno, Shinji Matsuba, et al.Clinical Ophthalmology (Auckland, N.Z.)|March 16, 2012
Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trialShunsuke Nakakura, Hitoshi Tabuchi, Yukio Baba, et al.Pageof 16